European Union - English - EMA (European Medicines Agency)

hikma farmaceutica (portugal) s.a. - voriconazole - bacterial infections and mycoses; aspergillosis; candidiasis - antimycotics for systemic use - voriconazole is a broad spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above as follows:treatment of invasive aspergillosis;treatment of candidaemia in non-neutropenic patients;treatment of fluconazole-resistant serious invasive candida infections (including c. krusei);treatment of serious fungal infections caused by scedosporium spp. and fusarium spp.voriconazole should be administered primarily to patients with progressive, possibly life-threatening infections.prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct)recipients.

Egypt - English - EDA (Egyptian Drug Authority)

hikma pharma - tablet - 5 mg

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - thiotepa (unii: 905z5w3gkh) (thiotepa - unii:905z5w3gkh) - thiotepa 15 mg in 1.5 ml - thiotepa for injection, usp has been tried with varying results in the palliation of a wide variety of neoplastic diseases. however, the most consistent results have been seen in the following tumors: - 1.adenocarcinoma of the breast. - 2.adenocarcinoma of the ovary. - 3.for controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities. - 4.for the treatment of superficial papillary carcinoma of the urinary bladder. while now largely superseded by other treatments, thiotepa has been effective against other lymphomas, such as lymphosarcoma and hodgkin's disease. thiotepa is contraindicated in patients with a known hypersensitivity (allergy) to this preparation. therapy is probably contraindicated in cases of existing hepatic, renal, or bone-marrow damage. however, if the need outweighs the risk in such patients, thiotepa may be used in low dosage, and accompanied by hepatic, renal and hemopoietic function tests.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - floxuridine (unii: 039lu44i5m) (floxuridine - unii:039lu44i5m) - floxuridine 100 mg in 1 ml - floxuridine for injection, usp is effective in the palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means. patients with known disease extending beyond an area capable of infusion via a single artery should, except in unusual circumstances, be considered for systemic therapy with other chemotherapeutic agents. floxuridine therapy is contraindicated for patients in a poor nutritional state, those with depressed bone marrow function or those with potentially serious infections.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - daunorubicin hydrochloride (unii: ud984i04lz) (daunorubicin - unii:zs7284e0zp) - daunorubicin hydrochloride in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. daunorubicin hydrochloride is contraindicated in patients who have shown a hypersensitivity to it.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - mitomycin (unii: 50sg953sk6) (mitomycin - unii:50sg953sk6) - mitomycin for injection, usp is not recommended as single-agent, primary therapy. it has been shown to be useful in the therapy of disseminated adenocarcinoma of the stomach or pancreas in proven combinations with other approved chemotherapeutic agents and as palliative treatment when other modalities have failed. mitomycin is not recommended to replace appropriate surgery and/or radiotherapy. mitomycin is contraindicated in patients who have demonstrated a hypersensitive or idiosyncratic reaction to it in the past. mitomycin is contraindicated in patients with thrombocytopenia, coagulation disorder, or an increase in bleeding tendency due to other causes.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

hikma pharmaceuticals plc, jordan - heparin sodium - solution for injection - 5000 iu/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

hikma pharmaceuticals plc, jordan - midazolam - solution for injection - 5 mg/ml

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - dacarbazine (unii: 7gr28w0fji) (dacarbazine - unii:7gr28w0fji) - dacarbazine for injection, usp is indicated in the treatment of metastatic malignant melanoma. in addition, dacarbazine is also indicated for hodgkin's disease as a second-line therapy when used in combination with other effective agents. dacarbazine is contraindicated in patients who have demonstrated a hypersensitivity to it in the past.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol sulfate inhalation aerosol is indicated in adults and children 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. albuterol sulfate inhalation aerosol is contraindicated in patients with a history of hypersensitivity to albuterol or any other albuterol sulfate inhalation aerosol component. read this instructions for use before you start using albuterol sulfate inhalation aerosol and each time you get a refill. there may be new information. this information does not take the place of talking to your doctor about your medical condition or treatment. your doctor should show you how your child should use albuterol sulfate inhalation aerosol. important information: albuterol sulfate inhalation aerosol comes as a canister with a dose indicator. the dose indicator is located on the top of the canister that fits into an actuator (see figure a ). the dose indicator display window will sho